Black Friday Sale! Save huge on InvestingProGet up to 60% off

UPDATE 2-Japan demands U.S. find drugs compromise in Pacific trade talks

Published 04/10/2015, 10:55 am
© Reuters.  UPDATE 2-Japan demands U.S. find drugs compromise in Pacific trade talks

(Adds New Zealand trade minister comments, byline)

By Kevin Krolicki and Krista Hughes

ATLANTA, Oct 3 (Reuters) - Japan called on the United States to find a way to break a deadlock over protections for next-generation medicines on Saturday as talks on a sweeping trade pact were extended for another 24 hours.

Negotiators have been up all night trying to broker a deal on the 12-nation Trans-Pacific Partnership, which will create a free trade zone covering 40 percent of the world economy.

A push by the United States to set a longer period of exclusivity for drug makers who develop biological drugs like Genentech's Avastin cancer-treatment has run into opposition from other TPP economies and is holding up a broader deal.

Japanese Economy Minister Akira Amari said he had agreed to a U.S. request to stay on in the southern city of Atlanta for another 24 hours, but said the United States had to find a way forward on biologics.

"I said there were two conditions for us to accept that proposal: first, this would be the last chance, in other words there had to be certainty of getting a deal on pharmaceuticals; second, because of the schedule, Japan could not accept any further extension," Amari told reporters.

The United States allows pharmaceutical companies an exclusive period of 12 years to use clinical data behind the approval for a new biological drug.

The Obama administration had previously proposed lowering that threshold to seven years but has pushed a proposal for an eight-year minimum in the TPP talks in Atlanta.

Australia, along with others such as New Zealand and Chile, have been unwilling to offer more than five years protection for the medicines since longer terms will push up the cost of state-subsidized medical programs.

New Zealand Trade Minister Tim Groser said the impasse is holding up a deal on trade in dairy products, New Zealand's main interest, and repeated that the country would not be pushed out of the pact. "We are not shooting for the stars," he said.

Groser warned that failing to seal a deal would have long-term strategic implications for the United States and all its trading partners. ID:nL1N1230RP

"You can see the summit within reach and it's just a question as to whether or not you've got just enough political energy to reach out and do the last little bit," he said.

Canadian Prime Minister Stephen Harper, whose party faces a general election later this month, said the talks had made progress.

"Let me assure everyone that we will only conclude a deal that is in the best interests of our country," he told reporters in Montreal.

Harper's Conservatives are on course to win the most seats in the Oct. 19 election but may lose their majority, and the main opposition party has said it would not feel itself bound by any TPP deal that Harper negotiated.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.